JHS Svendgaard Laboratories Ltd (JHS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 150728,
    "name": "JHS Sven.Lab.",
    "stock_name": "JHS Sven.Lab.",
    "full_name": "JHS Svendgaard Laboratories Ltd",
    "name_url": "stocks-analysis/jhs-svenlab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.40",
    "chg": -0.11,
    "chgp": "-1.29%",
    "dir": -1,
    "prev_price": "8.51",
    "mcapval": "76.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532771,
    "symbol": "JHS",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE544H01014",
    "curr_date": "Mar 16",
    "curr_time": "",
    "bse_nse_vol": "1.51 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 16, 2026",
    "traded_date_str": "2026 03 16",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jhs-svenlab-150728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "JHS Svendgaard Laboratories Ltd Hits 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-ltd-hits-52-week-low-amid-continued-downtrend-3893914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JHSSvendgaardLa_priceRelatedfactors_3893914.png",
        "date": "2026-03-16 12:11:29",
        "description": "JHS Svendgaard Laboratories Ltd has touched a new 52-week low of Rs.8.17 today, marking a significant decline in its stock price amid continued underperformance in the FMCG sector. The stock has been on a downward trajectory for the past three days, losing 9.03% in returns during this period and underperforming its sector by 0.71% today."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-3893320",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JHSSvendgaardLa_mojoScore_3893320.png",
        "date": "2026-03-16 10:10:02",
        "description": "JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd Falls to 52-Week Low of Rs.8.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-ltd-falls-to-52-week-low-of-rs855-3879754",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JHSSvendgaardLa_priceRelatedfactors_3879754.png",
        "date": "2026-03-09 11:13:22",
        "description": "JHS Svendgaard Laboratories Ltd has touched a new 52-week low of Rs.8.55 today, marking a significant decline in its stock price amid broader market weakness and persistent underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-3869023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JHSSvendgaardLa_mojoScore_3869023.png",
        "date": "2026-03-04 10:10:02",
        "description": "JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd Falls to 52-Week Low of Rs.8.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-ltd-falls-to-52-week-low-of-rs895-3869097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JHSSvendgaardLa_priceRelatedfactors_3869097.png",
        "date": "2026-03-04 10:07:32",
        "description": "JHS Svendgaard Laboratories Ltd has touched a fresh 52-week low of Rs.8.95 today, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial metrics and market sentiment."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-3849369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JHSSvendgaardLa_mojoScore_3849369.png",
        "date": "2026-02-21 10:10:05",
        "description": "JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 November 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are JHS Svendgaard Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jhs-svendgaard-laboratories-ltd-latest-results-good-or-bad-3833347",
        "imagepath": "",
        "date": "2026-02-11 19:26:22",
        "description": "The latest financial results for JHS Svendgaard Laboratories Ltd present a mixed picture of operational performance. In Q2 FY26, the company reported net sales of ₹22.28 crores, reflecting a year-on-year growth of 13.21% compared to ₹19.68 crores in Q2 FY25. However, this growth was accompanied by a net loss of ₹0.20 crores, a significant decline from the profit of ₹1.06 crores recorded in the previous quarter. This return to losses highlights ongoing challenges in achieving consistent profitability.\n\nOperating margins also showed a decline, with the operating profit margin falling to 4.08% from 7.08% in Q1 FY26. This contraction suggests potential issues such as increased costs or operational inefficiencies. Additionally, the profit after tax (PAT) margin turned negative at -0.90%, indicating further deterioration in financial performance.\n\nDespite the revenue growth, the company has faced chronic profitab..."
      },
      {
        "title": "JHS Svendgaard Q3 FY26: Profitability Remains Elusive Amid Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/jhs-svendgaard-q3-fy26-profitability-remains-elusive-amid-revenue-growth-3831709",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JHSSvendgaardLa_quaterlyResult_3831709.png",
        "date": "2026-02-10 20:01:07",
        "description": "JHS Svendgaard Laboratories Ltd., a micro-cap oral care products manufacturer, reported a net loss of ₹0.20 crores in Q2 FY26 (Jul-Sep'25), reversing from a profit of ₹1.06 crores in the previous quarter. The company's stock, currently trading at ₹10.80, has declined 2.96% following the results announcement and remains down 40.46% over the past year, significantly underperforming the FMCG sector's 4.92% gain. With a market capitalisation of just ₹99.00 crores and a troubling financial track record, the Himachal Pradesh-based manufacturer faces mounting challenges in restoring investor confidence."
      },
      {
        "title": "Are JHS Svendgaard Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jhs-svendgaard-laboratories-ltd-latest-results-good-or-bad-3831457",
        "imagepath": "",
        "date": "2026-02-10 19:23:06",
        "description": "The latest financial results for JHS Svendgaard Laboratories Ltd highlight a company grappling with significant operational challenges. In the quarter ended September 2025, the company reported net sales of ₹22.28 crores, reflecting a sequential decline of 4.99% from the previous quarter, although it did show a year-on-year growth of 13.21% compared to ₹19.68 crores in the same quarter last year. This mixed performance suggests that while there may be some seasonal demand, it does not indicate a sustainable growth trajectory.\n\nThe operating margin for the quarter was reported at 4.08%, a notable reduction from 7.08% in the previous quarter, indicating pressure on profitability. Furthermore, the company recorded a net loss of ₹0.20 crores, marking a significant reversal from the profit of ₹1.06 crores reported in the prior quarter. This loss underscores the ongoing difficulty in achieving consistent profitab..."
      }
    ],
    "total": 191,
    "sid": "150728",
    "stock_news_url": "https://www.marketsmojo.com/news/jhs-svendgaard-laboratories-150728"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "12-Feb-2026",
      "details": "Newspaper Publication of Financial Result for Quarter and Nine months ended 31 December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Nine Month Ended 31St December 2025",
      "datetime": "10-Feb-2026",
      "details": "To considered and approved the Un-Audited Financial Results for the Quarter and Nine Month Ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Grant Of ESOP",
      "datetime": "10-Feb-2026",
      "details": "Intimation of Grant of ESOP under JHS Svendgaard Laboratories Limited Employee Option Scheme 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "JHS Svendgaard Laboratories Ltd has declared <strong>8%</strong> dividend, ex-date: 26 Dec 11",
          "dt": "2011-12-26",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

JHS Svendgaard Laboratories Ltd Hits 52-Week Low Amid Continued Downtrend

2026-03-16 12:11:29

JHS Svendgaard Laboratories Ltd has touched a new 52-week low of Rs.8.17 today, marking a significant decline in its stock price amid continued underperformance in the FMCG sector. The stock has been on a downward trajectory for the past three days, losing 9.03% in returns during this period and underperforming its sector by 0.71% today.

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-03-16 10:10:02

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

JHS Svendgaard Laboratories Ltd Falls to 52-Week Low of Rs.8.55

2026-03-09 11:13:22

JHS Svendgaard Laboratories Ltd has touched a new 52-week low of Rs.8.55 today, marking a significant decline in its stock price amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-03-04 10:10:02

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

JHS Svendgaard Laboratories Ltd Falls to 52-Week Low of Rs.8.95

2026-03-04 10:07:32

JHS Svendgaard Laboratories Ltd has touched a fresh 52-week low of Rs.8.95 today, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial metrics and market sentiment.

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-02-21 10:10:05

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 November 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are JHS Svendgaard Laboratories Ltd latest results good or bad?

2026-02-11 19:26:22

The latest financial results for JHS Svendgaard Laboratories Ltd present a mixed picture of operational performance. In Q2 FY26, the company reported net sales of ₹22.28 crores, reflecting a year-on-year growth of 13.21% compared to ₹19.68 crores in Q2 FY25. However, this growth was accompanied by a net loss of ₹0.20 crores, a significant decline from the profit of ₹1.06 crores recorded in the previous quarter. This return to losses highlights ongoing challenges in achieving consistent profitability. Operating margins also showed a decline, with the operating profit margin falling to 4.08% from 7.08% in Q1 FY26. This contraction suggests potential issues such as increased costs or operational inefficiencies. Additionally, the profit after tax (PAT) margin turned negative at -0.90%, indicating further deterioration in financial performance. Despite the revenue growth, the company has faced chronic profitab...

Read full news article

JHS Svendgaard Q3 FY26: Profitability Remains Elusive Amid Revenue Growth

2026-02-10 20:01:07

JHS Svendgaard Laboratories Ltd., a micro-cap oral care products manufacturer, reported a net loss of ₹0.20 crores in Q2 FY26 (Jul-Sep'25), reversing from a profit of ₹1.06 crores in the previous quarter. The company's stock, currently trading at ₹10.80, has declined 2.96% following the results announcement and remains down 40.46% over the past year, significantly underperforming the FMCG sector's 4.92% gain. With a market capitalisation of just ₹99.00 crores and a troubling financial track record, the Himachal Pradesh-based manufacturer faces mounting challenges in restoring investor confidence.

Read full news article

Are JHS Svendgaard Laboratories Ltd latest results good or bad?

2026-02-10 19:23:06

The latest financial results for JHS Svendgaard Laboratories Ltd highlight a company grappling with significant operational challenges. In the quarter ended September 2025, the company reported net sales of ₹22.28 crores, reflecting a sequential decline of 4.99% from the previous quarter, although it did show a year-on-year growth of 13.21% compared to ₹19.68 crores in the same quarter last year. This mixed performance suggests that while there may be some seasonal demand, it does not indicate a sustainable growth trajectory. The operating margin for the quarter was reported at 4.08%, a notable reduction from 7.08% in the previous quarter, indicating pressure on profitability. Furthermore, the company recorded a net loss of ₹0.20 crores, marking a significant reversal from the profit of ₹1.06 crores reported in the prior quarter. This loss underscores the ongoing difficulty in achieving consistent profitab...

Read full news article

View All News